Medical and Scientific Advisory Board
The Leukemia & Lymphoma Society's (LLS's) Medical and Scientific Advisory Board is comprised of leading experts in their fields. Board members volunteer their time to LLS and receive no compensation for their generous support.
The Medical and Scientific Advisory Board's role is to advise the Board of Directors on a range of issues. These include periodically reviewing LLS's medical affairs and recommending funding for research grant awards.
Subcommittees within the Advisory Board work on specific processes that relate to medical and scientific affairs.
Officers
Steven T. Rosen, M.D., F.A.C.P., Chair
Northwestern University
Board Members
Frederick Appelbaum, M.D.
Fred Hutchinson Cancer Research Center
Steven Bernstein, M.D.
University of Rochester Medical Center
Department of Medicine
Alexandra Mayes Birnbaum
Peartree Communications, Inc.
Jorge E. Cortes, M.D.
The University of Texas, M.D. Anderson Cancer Center
Department of Leukemia
Jim Davis, Ph.D., J.D.
Former Human Genome Sciences
Russel K. Enns, Ph.D.
Cepheid
Sandra J. Horning, M.D.
Genentech, Inc.
Catriona Jamieson, M.D., Ph.D.
The Regents of the University of California, San Diego
Stem Cell Research Program
Alan F. List, M.D.
H. Lee Moffit Cancer Center & Research Institute
Robert S. Negrin, M.D.
Stanford University
Susan M. O'Brien
The University of Texas, M.D. Anderson Cancer Center
Department of Leukemia
Steven T. Rosen, M.D., F.A.C.P.
Northwestern University
Franklin O. Smith III, M.D.
Cincinnati Children's Hospital
Pediatric Hematology/Oncology
Nancy Speck, Ph.D.
University of Pennsylvania School of Medicine
Abramson Family Cancer Research Institute
Cell and Developmental Biology
Keith Stewart, M.D.
Mayo Clinic and Foundations
